ProShares Ultra Nasdaq Biotechnology (BIB) Short Interest Ratio & Short Volume $50.52 -0.03 (-0.06%) As of 01/17/2025 03:58 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends ProShares Ultra Nasdaq Biotechnology Short Interest DataProShares Ultra Nasdaq Biotechnology (BIB) has a short interest of 2,200 shares. This marks a -43.59% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 7,446 shares to cover all short positions.Current Short Interest2,200 sharesPrevious Short Interest3,900 sharesChange Vs. Previous Month-43.59%Dollar Volume Sold Short$111,452.00Short Interest Ratio0.2 Days to CoverLast Record DateDecember 31, 2024Outstanding Shares1,200,000 sharesPercentage of Shares Shorted0.18%Today's Trading Volume6,107 sharesAverage Trading Volume7,446 sharesToday's Volume Vs. Average82% Short Selling ProShares Ultra Nasdaq Biotechnology? Sign up to receive the latest short interest report for ProShares Ultra Nasdaq Biotechnology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBIB Short Interest Over TimeBIB Days to Cover Over TimeBIB Percentage of Float Shorted Over Time ProShares Ultra Nasdaq Biotechnology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/20242,200 shares $111,452.00 -43.6%N/A0.2 $50.66 12/15/20243,900 shares $212,706.00 -7.1%N/A0.3 $54.54 11/30/20244,200 shares $250,026.00 -52.8%N/A0.3 $59.53 11/15/20248,900 shares $477,574.00 +17.1%N/A0.7 $53.66 10/31/20247,600 shares $457,216.00 -54.8%N/A0.7 $60.16 10/15/202416,800 shares $1.08 million +100.0%N/A1.4 $64.43 Get the Latest News and Ratings for BIB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 9/30/20248,400 shares $535,542.00 -8.7%N/A0.6 $63.76 9/15/20249,200 shares $619,896.00 +5.8%N/A0.7 $67.38 8/31/20248,700 shares $586,119.00 -5.4%N/A0.6 $67.37 8/15/20249,200 shares $589,168.00 +76.9%N/A0.6 $64.04 7/31/20245,200 shares $347,334.00 -35.0%N/A0.3 $66.80 7/15/20248,000 shares $530,240.00 +220.0%N/A0.4 $66.28 6/30/20242,500 shares $148,150.00 -39.0%N/A0.1 $59.26 6/15/20244,100 shares $240,465.00 -26.8%N/A0.1 $58.65 5/31/20245,600 shares $314,104.00 -53.7%N/A0.2 $56.09 5/15/202412,100 shares $696,113.00 -25.3%N/A0.4 $57.53 4/30/202416,200 shares $817,290.00 -56.3%N/A0.5 $50.45 4/15/202437,100 shares $1.86 million +201.6%N/A0.9 $50.24 3/31/202412,300 shares $707,742.00 -77.9%N/A0.3 $57.54 3/15/202455,700 shares $3.12 million +98.2%N/A1.3 $56.04 2/29/202428,100 shares $1.62 million +53.6%N/A0.7 $57.80 2/15/202418,300 shares $1.06 million +2.2%N/A0.6 $58.07 1/31/202417,900 shares $1.02 million No ChangeN/A0.5 $57.11 BIB Short Interest - Frequently Asked Questions What is ProShares Ultra Nasdaq Biotechnology's current short interest? Short interest is the volume of ProShares Ultra Nasdaq Biotechnology shares that have been sold short but have not yet been closed out or covered. As of December 31st, traders have sold 2,200 shares of BIB short. Learn More on ProShares Ultra Nasdaq Biotechnology's current short interest. Is ProShares Ultra Nasdaq Biotechnology's short interest increasing or decreasing? ProShares Ultra Nasdaq Biotechnology saw a drop in short interest in the month of December. As of December 31st, there was short interest totaling 2,200 shares, a drop of 43.6% from the previous total of 3,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does ProShares Ultra Nasdaq Biotechnology's short interest compare to its competitors? Here is how the short interest of companies compare to ProShares Ultra Nasdaq Biotechnology: Invesco Nasdaq Biotechnology ETF (0.24%), First Trust Nasdaq Pharmaceuticals ETF (0.27%), JPMorgan Healthcare Leaders ETF (0.07%), Invesco Dorsey Wright Healthcare Momentum ETF (0.06%), ProShares UltraShort Nasdaq Biotechnology (20.90%), VanEck Biotech ETF (0.07%), VanEck Pharmaceutical ETF (39.75%), and iShares Biotechnology ETF (23.11%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short ProShares Ultra Nasdaq Biotechnology stock? Short selling BIB is an investing strategy that aims to generate trading profit from ProShares Ultra Nasdaq Biotechnology as its price is falling. BIB shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ProShares Ultra Nasdaq Biotechnology? A short squeeze for ProShares Ultra Nasdaq Biotechnology occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BIB, which in turn drives the price of the stock up even further. How often is ProShares Ultra Nasdaq Biotechnology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BIB, twice per month. The most recent reporting period available is December, 31 2024. More Short Interest Resources from MarketBeat Related Companies IBBQ Short Squeeze FTXH Short Squeeze JDOC Short Squeeze PTH Short Squeeze BIS Short Squeeze BBH Short Squeeze PPH Short Squeeze IBB Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BIB) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | SponsoredBitcoin to $200K?Newsweek recently asked several analysts whether they think Bitcoin will hit $200,000 by the end of 2025. T...Stansberry Research | SponsoredElon's "Final Move" Could Send This Stock SoaringWhenever Elon Musk starts a new venture... Early investors get the opportunity to become millionaires... ...Behind the Markets | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares Ultra Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares Ultra Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
